目的:探讨N-cadherin在人类卵巢癌组织中的表达及其临床.病理意义。方法:采用免疫组织化学染色法检测281例卵巢癌患者肿瘤组织中N-cadherin的表达,并分析其与患者临床病理特征之间的关系。结果:N-cadherin在卵巢癌原发灶中的表达显著低于配对的转移灶(P=0.018);卵巢癌组织中N-cadherin的表达与患者FIGO分期(P=O.034)、组织学类型(P〈0.001)、肿瘤分级(P=0.004)均显著相关。结论:N-cadherin高表达更多见于进展期(FIGOⅡ-Ⅳ)0t7巢癌、高级别浆液性癌及高级别卵巢癌,可能与卵巢癌细胞的侵袭及迁移能力呈正相关.对判断卵巢癌的生物举行为具有重要的参孝价值.
Objective: To explore the expression of N-cadherin and its correlations with the clinicopathological features of human ovarian carcinoma. Methods: The expression of N-cadherin in 281 cases of ovarian carcinoma tissues were determined by immunohistochemical method. The correlations of N-cadherin expression with the clinicopathological features of human ovarian carcinoma were analyzed. Results: There was higher expression of N-cadherin in the metastatic lesions than its paired primary lesions (P = 0.018). The expression level of N-cadherin in ovarian carcinoma was correlated with the FIGO stage (P = 0.034), histological type (P 〈 0.001) and tumor grade (P = 0.004). Conclusions: High expression of N-cadherin might positively correlate with the invasion and migration ability of ovarian carcinoma cells, which was more common in the the advanced (FIGO II-IV) ovarian carcinoma, high-grade serous carcinoma, and high grade ovarian carcinoma. N-cadherin might be useful in estimating the biological behavior of human ovarian carcinoma.